Effects of Nutraperf Consumption in Runners

Nutrition Processes Clinical Trial

Official title:

Identification of the Effects of NUTRAPERF Consumption on Performance in Endurance-Type Exercise.

Clinical Trial Details — Status: Completed

Administrative data

• NCT number: NCT00799630
• Other study ID #: 2008-A00982-53
• Status: Completed
• Phase: N/A
• First received: November 7, 2008
• Last updated: November 28, 2008
• Start date: November 2008

Study information

• Verified date: November 2008
• Source: Lescuyer Laboratory
• Contact: n/a
• Is FDA regulated: No
• Health authority: France: Institutional Ethical Committee
• Study type: Interventional

Clinical Trial Summary

Exercise has numerous health benefits. Nevertheless, when exercise duration is ~45 min or longer and intensity moderate to intense, it may induce different troubles, for example: hypoglycemia, peripheral and central fatigue, muscle damages, osteoarticular injuries, inflammation, cardiovascular dysfunctions. Nutritional loading during exercise may prevent and and/or reduce some of these troubles.

In regard of recent data, we proposed a novel energy drink (NUTRAPERF®) to limit deleterious effects of long time exercise in neutral environment (outside temperature between 4 and 25°C) and to improve performance. If performance may be increased by this energy drink during long time exercise, we proposed that it consumption may also improve performance in short and sub-maximal exercise.

So, the purpose of this study is to investigate the effects of the consumption of this novel energy drink on performance during long and short time exercise. Moreover, we studied the effects of this consumption on different metabolic parameters (heart rate, oxygen consumption, respiratory quotient, ventilation, glycemia, lactatemia), on central and peripheral fatigue and on cognitive parameters.

Recruitment information / eligibility

• Status: Completed
• Enrollment: 14
• Accepts healthy volunteers: Accepts Healthy Volunteers
• Gender: Male
• Age group: 18 Years to 45 Years

Eligibility

Inclusion criteria

• Man aged between 18 and 45 years.

• Regular sportsman (2 to 4 workouts by week since 3 months minimum).

• Be a long-distance runner.

• Be affiliated or beneficial to the National French Security Social.

Non-inclusion criteria

• Any subject who was injured during the three preceding months study.

• Any subject with a history of disease can disrupt the tests. In particular, subjects with pathological conditions placed on the joints of the knee or ankle (sprain repeated problems or patellar ligament) that could hamper measures of force maximum extension and flexion on these joints or illnesses that prevent the exercise of pedalling or running on treadmill (tendonitis, periostitis) will be excluded.

• Any subject who at the same time participates at another medical experiment.

Study Design

Allocation: Randomized, Endpoint Classification: Efficacy Study, Intervention Model: Crossover Assignment, Masking: Double Blind (Subject, Caregiver, Investigator)

Related Conditions & MeSH terms

• Nutrition Processes

Intervention

Dietary Supplement:
• Carbohydrate drink
Maltodextrins, dextrose, fructose, amino acids (leucine, isoleucine, valine), natural flavors, sodium chloride, magnesium citrate, zinc, lactate, acid: malic acid, anti-caking agent: silicon dioxide; Curcumin (turmeric extract) , Thickener: xanthan gum, caffeine, vitamin C (Acerola extract), vitamin E - B1 - B2 - B3; piperine (black pepper extract).

Locations

Country	Name	City	State
France	Service de Physiologie Clinique et de l'Exercice, CHU Saint-Etienne	Saint-Etienne

Sponsors (3)

Lead Sponsor	Collaborator
Lescuyer Laboratory	Centre Hospitalier Universitaire de Saint Etienne, Université Savoie Mont Blanc

Country where clinical trial is conducted

France,